🇫🇷
France · FR · FR:66966299
NAGLAZYME 1 mg/ml, solution à diluer pour perfusion
ATC A16AB08
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerBIOMARIN INTERNATIONAL LIMITED (IRLANDE)
CountryFR (France)
ATC codeA16AB08
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009567218701 flacon(s) en verre de 5 ml
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "66966299",
"date_amm": "2006-01-24",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/05/324",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code A16AB08.
- FINaglazymeBiomarin International Limited
- DKNaglazymeBioMarin International Limited
- ISNaglazymeBioMarin International Limited
- NONaglazymeBioMarin International Limited
- PLNaglazymeBioMarin International Ltd.
- 🇨🇭NaglazymeDRAC AG
- 🇺🇸NAGLAZYMEBioMarin Pharmaceutical Inc.
- CZNAGLAZYMEBioMarin International Limited, Dublin
Access this data programmatically
Query NAGLAZYME 1 mg/ml, solution à diluer pour perfusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.